|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.9 TWD | +1.70% |
|
+4.82% | +6.94% |
Welgene Biotech Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 321.9 million compared to TWD 312.65 million a year ago. Net income was TWD 9.55 million compared to TWD 13.7 million a year ago.
Basic earnings per share from continuing operations was TWD 0.41 compared to TWD 0.59 a year ago. Diluted earnings per share from continuing operations was TWD 0.41 compared to TWD 0.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.94% | 17.17M | |
| +49.45% | 57.87B | |
| +41.65% | 40.25B | |
| -6.59% | 39.94B | |
| -5.96% | 28.54B | |
| +13.02% | 26.4B | |
| -19.80% | 19.33B | |
| +32.49% | 12.4B | |
| -0.12% | 12.23B | |
| +25.19% | 12.2B |
WELGENE BIOTECH CO.,LTD. 